Different outcomes of AI-read vs human-read endoscopies in the TITRATE study (Medicom)

A post-hoc analysis of the TITRATE study showed that personalised infliximab dosing was superior to standard dosing in patients with acute severe ulcerative colitis (UC) when endoscopies were assessed using an artificial intelligence (AI)- assisted scoring tool. This effect was not observed in the primary analysis, where human readers evaluated endoscopies using the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).